3rd Quarter - Report

ZERO PROSTATE CANCER for ZERO PROSTATE CANCER

Firm
Client
Income
—
Expenses
$130,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

FY2026 Appropriations. Defense - Prostate Cancer Research Program; L-HHS - Prostate Cancer Activities, Division of Cancer Prevention and Control at the CDC, National Cancer Institute, National Institutes of Health

LobbyistCovered position, as disclosed
HILLEL BERGER —
ALISON MANSON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Health Issues HCR

HR 1300/S 293 PSA Screening for HIM Act - eliminating cost sharing for prostate cancer screening

LobbyistCovered position, as disclosed
HILLEL BERGER —
ALISON MANSON —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1300 (119th)

Insurance INS

HR 1300/S 293 PSA Screening for HIM Act - eliminating cost sharing for prostate cancer screening, extension of enhanced Advance Premium Tax Credits for Marketplace plans

LobbyistCovered position, as disclosed
HILLEL BERGER —
ALISON MANSON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1300 (119th)

Veterans VET

VA Precision Oncology Program for Cancer of the Prostate

LobbyistCovered position, as disclosed
HILLEL BERGER —
ALISON MANSON —

Contacted: Veterans Affairs, Dept of (VA); HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.